AstraZeneca shareholders approve Alexion acquisition
11th May 2021 13:59
(Sharecast News) - AstraZeneca's acquisition of Alexion Pharmaceuticals is set to close in the third quarter after shareholders voted in favour of the deal.
Read moreMonday broker round-up
10th May 2021 13:05
(Sharecast News) - St Modwen: Liberum downgrades to hold with a target price of 542p.
Read moreSunday newspaper round-up: AstraZeneca, Virgin Atlantic, Boohoo
9th May 2021 20:21
(Sharecast News) - AstraZeneca boss Pascal Soriot was last night at the centre of an extraordinary row among City investors over his multi-million-pound bonus. The French chief executive has been lauded for rolling out Astra's life-saving Covid vaccine at no profit, as well as fighting off predatory buyers and boosting the company's share price since he took charge in 2012. But Astra's major shareholders are understood to have been locked in heated talks for days after the drugs giant proposed to boost his bonus and performance-related share award by £2.3million to £12million. - Financial Mail on Sunday
Read moreUK to give under 40s alternative to AstraZeneca vaccine
7th May 2021 09:49
(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.
Read moreAstraZeneca's Imfinzi demonstrates benefit in combination with antibody
7th May 2021 07:42
(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.
Read moreThursday broker round-up
6th May 2021 13:43
(Sharecast News) - National Grid: Berenberg upgrades to buy with a target price of 1,100p.
Read moreAstraZeneca's Forxiga gets US approval for chronic kidney disease
4th May 2021 07:23
(Sharecast News) - AstraZeneca said on Tuesday that Farxiga has been approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes.
Read moreEU nations push for Valneva Covid-19 vaccine approval
30th Apr 2021 15:35
(Sharecast News) - Some countries from the European Union, including France and Germany, are pushing Brussels to strike a deal to buy Valneva's Covid-19 vaccine candidate despite a recent setback in talks.
Read moreAstraZeneca predicts faster growth after 'robust' Q1
30th Apr 2021 07:02
(Sharecast News) - AstraZeneca said it expected performance to accelerate as the drugs company reported "robust" revenue growth for the first quarter.
Read moreLondon open: Stocks dip despite tentative moves to reopen international travel
26th Apr 2021 08:38
(Sharecast News) - Stocks are coming under a little bit of selling pressure at the start of trading on Monday as investors monitor the headlines out of Asia concerning the epidemic and its possible impact on economies.
Read moreAstraZeneca upbeat on raft of positive data
26th Apr 2021 07:18
(Sharecast News) - AstraZeneca announced on Monday that the 'MELODY' phase 3 trial for 'nirsevimab' met its primary endpoint of a statistically significant reduction in the incidence of medically-attended lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) compared to placebo in healthy late preterm and term infants during their first RSV season.
Read moreEU prepares case against AstraZeneca for failed vaccine deliveries
22nd Apr 2021 09:23
(Sharecast News) - The European Commission is working on legal proceedings against AstraZeneca after the drugmaker failed to deliver the Covid-19 vaccines that it had been contracted for with the European Union.
Read moreWednesday broker round-up
21st Apr 2021 12:35
(Sharecast News) - Avast: Canaccord initiates at buy with a target price of 550.0p.
Read moreEU secures further 100m doses of Pfizer-BioNTech vaccine
19th Apr 2021 12:48
(Sharecast News) - The European Union has exercised its option for a further 100m doses of the Pfizer-BioNTech Covid-19 vaccine, the two drug companies confirmed on Monday.
Read moreAustralia reports first blood clot fatality 'linked' to AstraZeneca vaccine
16th Apr 2021 14:37
(Sharecast News) - Australia reported its first fatality from blood-clots related to the AstraZeneca vaccine on Friday.
Read more